← Eichor
Location: Pittsburgh Synced from ClinicalTrials.gov · July 28, 2026

Clinical studies recruiting near Pittsburgh

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

The PREDICT Registry:
Phase N/A · AHN Allegheny General Hospital · PreludeDx · NCT03448926
Left Atrial Strain and Cryptogenic Stroke
Phase N/A · UPMC Presbyterian · University of Pittsburgh · NCT07224178
Adoptive Cell Therapy Long-term Follow-up (LTFU) Study
Phase 1 · University of Pittsburgh Medical Center (UPMC) Hillman Cance · USWM CT, LLC · NCT03391778
PumaRx Registry Trial
Phase N/A · University of Pennsylvania Medical Center · RenovoRx · NCT06805461
Product Surveillance Registry
Phase N/A · Medtronic · NCT01524276
Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD
Phase 2 · University of Pittsburgh · Johns Hopkins University · NCT07059091
Imaging CRF X NOP Interactions in CUD
EARLY_Phase 1 · University of Pittsburgh · Rajesh Narendran · NCT05008146
Safety Study of Unlicensed IND Cord Blood Units Manufactured by the National Cord Blood Program for Unrelated Transplant
Phase 2 · Children's Hopsital of Pittsburgh of UPMC · New York Blood Center · NCT01656603
Neoadjuvant Darovasertib in Primary Uveal Melanoma
Phase 3 · UPMC Hillman Cancer Center · IDEAYA Biosciences · NCT07015190
Heated Intraperitoneal Chemotherapy Followed by Niraparib for Ovarian, Primary Peritoneal and Fallopian Tube Cancer
Phase 3 · West Penn Hospital · GOG Foundation · NCT05659381
Study to Explore the Therapeutic Effect of Eluxadoline in Treating Irritable Bowel Syndrome With Diarrhea in Children
Phase 2 · Preferred Primary Care Physicians, Inc. /ID# 236436 · AbbVie · NCT03339128
Simvastatin Treatment to Improve Patient-reported Outcomes in Patients With Chronic Pancreatitis
EARLY_Phase 1 · University of Pittsburgh Medical Center · Cedars-Sinai Medical Center · NCT05771675
Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers
Phase 2 · Children's Hospital of Pittsburgh of UPMC · Fred Hutchinson Cancer Center · NCT03779854
CEM to Reduce Biopsy Rates for Less Than Highly Suspicious Breast Abnormalities: a Prospective Study
Phase 4 · UPMC Magee-Womens Hospital · Margarita Louise Zuley · NCT05206331
A Study Evaluating BFB759 in Moderate to Severe Atopic Dermatitis
Phase 2 · UPMC · Bluefin Biomedicine, Inc. · NCT07105488
Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Remo
Phase 2/Phase 3 · UPMC-Saint Margaret · National Cancer Institute (NCI) · NCT05987241
Safety Study of SMOFlipid to Evaluate the Risk of Developing EFAD and/or PNAC in Pediatric and Adult Patients
Phase 4 · Children's Hospital of Pittsburgh of UPMC · Fresenius Kabi · NCT06049680
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Neg
Phase 3 · UPMC Magee-Womens Hospital · Gilead Sciences · NCT05633654
A Study of Dostarlimab vs Placebo After Chemoradiation in Adult Participants With Locally Advanced Unresected Head and N
Phase 3 · GSK Investigational Site · GlaxoSmithKline · NCT06256588
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
Phase N/A · West Penn Hosp · Stryker Instruments · NCT03072927
DFC 004 Biomarkers for Active Diabetic Foot Ulcers
Phase N/A · University of Pittsburgh · University of Michigan · NCT06104969
A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Canc
Phase 3 · University Of Pittsburgh Medical Center UPMC Hillman Cancer · Janssen Research & Development, LLC · NCT07225946
Transdiagnostic Sleep and Circadian Intervention + Bright Light in Adolescents With Elevated Depression (TranS-C+BL)
NA · University of Pittsburgh · University of Pittsburgh · NCT06963463
GYNEMESH PS Mesh Post Marketing Clinical Follow-Up Study
Phase N/A · UMPC · Ethicon, Inc. · NCT04829058
Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With G
Phase 2/Phase 3 · University of Pittsburgh Cancer Institute (UPCI) · ECOG-ACRIN Cancer Research Group · NCT07001748
Evaluating the Impact of Social and Genetic Factors on Outcomes in Adolescent and Young Adult Cancer Survivors
Phase N/A · ECOG-ACRIN Cancer Research Group · NCT06002828
Malabsorption Blood Test (MBT) to Determine Exocrine Pancreatic Function and Related Quality of Life in Chronic Pancreat
Phase 4 · University of Pittsburgh Medical Center · Anna Evans Phillips · NCT07418593
A Study to Learn More About How Well Sevabertinib Works and How Safe it is Compared With Standard Treatment, in Particip
Phase 3 · Allegheny General Hospital · Bayer · NCT06452277
Real-Time Diagnosis of Life-Threatening Necrotizing Soft Tissue Infections (NSTI) Using Indocyanine Green (ICG) Kinetic
Phase N/A · University of Pittsburgh Medical Center · Eric R. Henderson · NCT06877793
Dietary Interventions in Cancer Patients Treated With Immune Checkpoint Inhibitors
NA · UPMC Hillman Cancer Center · University of Pittsburgh · NCT06475807
Look up another city
Look up another condition

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.